{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:20:59Z","timestamp":1781623259357,"version":"3.54.5"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The number of patients with hepatocellular carcinoma (HCC) caused by hepatitis B virus (HBV) infection remains large, despite the remarkable effectiveness of antiviral drugs and vaccines for HBV in preventing and treating HBV infection. Necroptosis is closely related to the occurrence of inflammation, clearance of viral infection, and tumor progression. Presently, little is known about the changes in necroptosis-related genes in the progression from chronic HBV infection (CHI) to HBV-related hepatic fibrosis (HBV-HF) and HBV-related hepatocellular carcinoma (HBV-HCC). In this study, Cox regression analysis was performed using GSE14520 chip data and a necroptosis-related genes survival prognosis score (NRGPS) was established for HBV-HCC patients. NRGPS was constructed using three model genes (G6PD, PINK1 and LGALS3), and verified by data sequencing in the TCGA database. The HBV-HCC cell model was established by transfection of pAAV\/HBV1.2<jats:sub>C2<\/jats:sub>, constructed by homologous recombination, into HUH7 and HEPG2 cells. The expression levels of G6PD, PINK1, and LGALS3 were detected using RT-qPCR. We further analyzed the expression of the model genes in GSE83148, GSE84044, and GSE14520 and found that LGALS3 was consistently highly expressed in CHI, high fibrosis score and high NRGPS. In addition, immune microenvironment analysis showed that LGALS3 was not only associated with the infiltration of regulatory T cells in the immune microenvironment but also with expression of CCL20 and CCR6. The expression levels of model genes, FOXP3 and CCR6, were analyzed using RT-qPCR in peripheral blood mononuclear cells of 31 hepatitis B surface antibody positive patients, 30 CHI, 21 HBV-HF, and 20 HBV-HCC. In further cell-model experiments, we analyzed the expression of CCL20 by RT-qPCR and the changes in cell proliferation and migration by CCK8 and transwell assays, respectively, in HBV-HCC cell models after LGALS3 knockdown. The findings of this study suggest that LGALS3 could be a biomarker for adverse progression following chronic HBV infection and may also be involved in the regulation of the immune microenvironment, making it a potential therapeutic target.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1142319","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:59:50Z","timestamp":1682485190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC"],"prefix":"10.3389","volume":"14","author":[{"given":"Jianming","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis b virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6764379","article-title":"The immune landscape of hepatitis b virus-related acute liver failure by integration analysis","volume":"2022","author":"Gong","year":"2022","journal-title":"J Immunol Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.06.103","article-title":"MLKL and FADD are critical for suppressing progressive lymphoproliferative disease and activating the NLRP3 inflammasome","volume":"16","author":"Zhang","year":"2016","journal-title":"Cell Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41418-018-0172-x","article-title":"Necroptosis in anti-viral inflammation","volume":"26","author":"Nailwal","year":"2019","journal-title":"Cell Death Differ"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5 n-glycosylation","volume":"409","author":"Demetriou","year":"2001","journal-title":"Nature"},{"key":"B7","article-title":"Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells","volume":"59","author":"Kim","year":"1999","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.744518","article-title":"Role of galectins in the liver diseases: A systematic review and meta-analysis","volume":"8","author":"An","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9949","article-title":"Galectin-3 not galectin-9 as a candidate prognosis marker for hepatocellular carcinoma","volume":"8","author":"Kong","year":"2020","journal-title":"PeerJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24346","article-title":"A multi-omics-based investigation of the immunological and prognostic impact of necroptosis-related genes in patients with hepatocellular carcinoma","volume":"36","author":"Yang","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4812","article-title":"A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma","volume":"11","author":"Chen","year":"2022","journal-title":"Cancer Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3172099","article-title":"Identification and validation of prognosis-related necroptosis genes for prognostic prediction in hepatocellular carcinoma","volume":"2022","author":"Gao","year":"2022","journal-title":"J Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.900713","article-title":"Establishment of a necroptosis-related prognostic signature to reveal immune infiltration and predict drug sensitivity in hepatocellular carcinoma","volume":"13","author":"Ren","year":"2022","journal-title":"Front Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e30219","DOI":"10.1097\/MD.0000000000030219","article-title":"Identification and validation of the necroptosis-related gene signature related to prognosis and tumor immune in hepatocellular carcinoma","volume":"101","author":"Xiang","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.984297","article-title":"A necroptosis-related prognostic model for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma based on single-cell sequencing analysis and weighted co-expression network","volume":"21","author":"Li","year":"2022","journal-title":"Front Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis b virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2060776","article-title":"circHIPK3 regulates cell proliferation and migration by sponging microRNA-124 and regulating serine\/threonine kinase 3 expression in esophageal squamous cell carcinoma","volume":"13","author":"Yao","year":"2022","journal-title":"Bioengineered"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081977","article-title":"Cytospin-a regulates colorectal cancer cell division and migration by modulating stability of microtubules and actin filaments","volume":"14","author":"Fan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41419-022-05181-1","article-title":"Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling","volume":"13","author":"Bai","year":"2022","journal-title":"Cell Death Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075361","article-title":"Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease","volume":"8","author":"Traber","year":"2013","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2020.11.001","article-title":"Overexpression of galectin-1 and galectin-3 in hepatocellular carcinoma","volume":"4","author":"Setayesh","year":"2020","journal-title":"Liver Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19990517)81:4<519::aid-ijc3>3.0.co;2-0","article-title":"Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma","volume":"81","author":"Hsu","year":"1999","journal-title":"Int J Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jbior.2018.09.003","article-title":"Galectins as regulators of cell survival in the leukemia niche","volume":"71","author":"Ruvolo","year":"2019","journal-title":"Adv Biol Regul"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.889034","article-title":"Galectin family members: Emerging novel targets for lymphoma therapy","volume":"12","author":"Shi","year":"2022","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis b reactivation associated with immune suppressive and biological modifier therapies: Current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxl130","article-title":"Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis b","volume":"19","author":"Yang","year":"2007","journal-title":"Int Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni.f.214","article-title":"Chemokines and leukocyte traffic","volume":"9","author":"Sallusto","year":"2008","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2014.11.029","article-title":"The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended","volume":"72","author":"Lee","year":"2015","journal-title":"Cytokine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/nsr\/nwu038","article-title":"The hepatitis b virus-associated tumor microenvironment in hepatocellular carcinoma","volume":"1","author":"Yang","year":"2014","journal-title":"Natl Sci Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024671","article-title":"Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis","volume":"6","author":"Chen","year":"2011","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-010-0833-8","article-title":"Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma","volume":"136","author":"Shen","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25765","article-title":"Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis b virus infection in mice","volume":"56","author":"Stross","year":"2012","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/path.5856","article-title":"MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation","volume":"256","author":"Yuan","year":"2022","journal-title":"J Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1038\/s41467-022-35334-x","article-title":"Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2013.12.009","article-title":"Evaluation of annexin A7, galectin-3 and gelsolin as possible biomarkers of hepatocarcinoma lymphatic metastasis","volume":"68","author":"Wang","year":"2014","journal-title":"BioMed Pharmacother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1142319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:59:53Z","timestamp":1682485193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1142319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2023.1142319"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1142319","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"article-number":"1142319"}}